Therapy of Cushing's syndrome with steroid biosynthesis inhibitors
- 1 June 1994
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 49 (4-6) , 261-267
- https://doi.org/10.1016/0960-0760(94)90267-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Medical Treatment of Cushing's SyndromeEndocrine Reviews, 1993
- Short and long‐term responses to metyrapone in the medical management of 91 patients with Cushing's syndromeClinical Endocrinology, 1991
- THE COMBINED USE OF SODIUM VALPROATE AND METYRAPONE IN THE TREATMENT OF CUSHING'S SYNDROMEClinical Endocrinology, 1988
- EXPERIENCE WITH TRILOSTANE IN THE TREATMENT OF CUSHING'S SYNDROMEClinical Endocrinology, 1983
- Trilostane, an orally active inhibitor of steroid biosynthesisSteroids, 1978
- Metyrapone Is Useful Only as Adjunctive Therapy in Cushing's DiseaseAnnals of Internal Medicine, 1978
- Aminoglutethimide in the Treatment of Cushing's SyndromeThe Journal of Clinical Pharmacology, 1976
- Dual Sites of Inhibition by Metyrapone of Human Adrenal Steroidogenesis: Correlation ofin Vivoand andin VitroStudiesJournal of Clinical Endocrinology & Metabolism, 1976
- Results of Treatment in 108 Patients with Cushing's SyndromeNew England Journal of Medicine, 1971
- Inhibition of Adrenal Corticosteroid Synthesis by Aminoglutethimide: Studies of the Mechanism of Action1Journal of Clinical Endocrinology & Metabolism, 1967